Mayence, A., & Vanden Eynde, J. J. (2019). Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium vivax Malaria and Prophylaxis of Malaria. Pharmaceuticals (Basel).
Chicago-стиль цитированияMayence, Annie, and Jean Jacques Vanden Eynde. "Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium Vivax Malaria and Prophylaxis of Malaria." Pharmaceuticals (Basel) 2019.
MLA-цитированиеMayence, Annie, and Jean Jacques Vanden Eynde. "Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of Plasmodium Vivax Malaria and Prophylaxis of Malaria." Pharmaceuticals (Basel) 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.